Shandong Wohua Pharmaceutical Co Ltd (002107) — Working Capital to Net Assets Ratio

Latest as of December 2025: 45.2%

Shandong Wohua Pharmaceutical Co Ltd (002107) has a Working Capital to Net Assets ratio of 45.2% as of December 2025. Working capital of CN¥326.04 Million (current assets of CN¥566.77 Million minus current liabilities of CN¥240.73 Million) is measured against net assets of CN¥720.90 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Shandong Wohua Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

WC/NA Ratio

45.2%
Working Capital / Net Assets

Working Capital

CN¥326.04 Million
CNY

Current Assets

CN¥566.77 Million
CNY

Current Liabilities

CN¥240.73 Million
CNY

Shandong Wohua Pharmaceutical Co Ltd Working Capital to Net Assets (2003–2025)

This chart shows how Shandong Wohua Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2003 to 2025. As of December 2025, the ratio stands at 45.2%, reflecting working capital of CN¥326.04 Million against net assets of CN¥720.90 Million CNY. Check Shandong Wohua Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 002107 market cap overview.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2025 45.2% CN¥326.04 Million CN¥720.90 Million CN¥566.77 Million CN¥240.73 Million ▲ +3.6 pp
2024 41.6% CN¥300.83 Million CN¥722.93 Million CN¥543.12 Million CN¥242.29 Million ▼ -4.6 pp
2023 46.2% CN¥385.01 Million CN¥833.48 Million CN¥673.00 Million CN¥287.99 Million ▲ +6.2 pp
2022 40.0% CN¥315.76 Million CN¥789.79 Million CN¥599.21 Million CN¥283.44 Million ▼ -4.9 pp
2021 44.9% CN¥416.82 Million CN¥929.26 Million CN¥620.57 Million CN¥203.74 Million ▲ +4.5 pp
2020 40.4% CN¥370.52 Million CN¥918.01 Million CN¥794.17 Million CN¥423.64 Million ▼ -12.1 pp
2019 52.4% CN¥406.47 Million CN¥775.15 Million CN¥619.21 Million CN¥212.74 Million ▲ +2.3 pp
2018 50.1% CN¥348.62 Million CN¥695.78 Million CN¥561.59 Million CN¥212.97 Million ▼ -3.1 pp
2017 53.2% CN¥348.77 Million CN¥655.78 Million CN¥538.62 Million CN¥189.85 Million ▲ +3.5 pp
2016 49.7% CN¥284.75 Million CN¥572.64 Million CN¥378.91 Million CN¥94.16 Million ▲ +1.4 pp
2015 48.3% CN¥264.32 Million CN¥547.26 Million CN¥346.28 Million CN¥81.96 Million ▼ -15.4 pp
2014 63.7% CN¥402.51 Million CN¥631.74 Million CN¥435.30 Million CN¥32.79 Million ▲ +3.6 pp
2013 60.1% CN¥363.80 Million CN¥605.04 Million CN¥400.16 Million CN¥36.37 Million ▲ +1.8 pp
2012 58.3% CN¥346.57 Million CN¥594.41 Million CN¥386.86 Million CN¥40.28 Million ▼ -5.2 pp
2011 63.5% CN¥372.43 Million CN¥586.07 Million CN¥408.71 Million CN¥36.28 Million ▼ -0.4 pp
2010 63.9% CN¥377.62 Million CN¥590.64 Million CN¥413.12 Million CN¥35.49 Million ▼ -6.5 pp
2009 70.4% CN¥484.69 Million CN¥688.45 Million CN¥560.10 Million CN¥75.41 Million ▲ +6.6 pp
2008 63.8% CN¥406.94 Million CN¥637.88 Million CN¥479.49 Million CN¥72.54 Million ▲ +10.2 pp
2007 53.6% CN¥183.47 Million CN¥342.22 Million CN¥271.07 Million CN¥87.60 Million ▲ +33.3 pp
2006 20.3% CN¥28.90 Million CN¥142.57 Million CN¥120.94 Million CN¥92.04 Million ▼ -34.5 pp
2005 54.8% CN¥60.88 Million CN¥111.06 Million CN¥142.66 Million CN¥81.78 Million ▲ +18.2 pp
2004 36.6% CN¥30.27 Million CN¥82.62 Million CN¥98.86 Million CN¥68.59 Million ▲ +40.8 pp
2003 -4.2% CN¥-2.17 Million CN¥51.69 Million CN¥80.40 Million CN¥82.57 Million
pp = percentage points